Karthik Radhakrishnan

Chief Financial Officer, Opexa Therapeutics.

Companies

Monopar TherapeuticsChief financial officer Jul 3, 2024 to Oct 30, 2024¹
Opexa TherapeuticsChief financial officer Apr 1, 2013 to Apr 9, 2015²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Monopar Therapeutics MNPR1,550 shares³$109.7K at $70.76Oct 28, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 28, 2024Bought 1,550 shares at $16.25 of Monopar Therapeutics³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMonopar Therapeutics, Chief financial officer
2
SEC EDGAROpexa Therapeutics, Chief financial officer
3
SEC EDGARMonopar Therapeutics shares after the filing of Oct 28, 2024